CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,162,000 | -88.0% | 976,384 | -81.9% | 0.00% | -83.3% |
| Q2 2022 | $9,721,000 | +33.6% | 5,400,324 | +49.9% | 0.01% | +50.0% |
| Q1 2022 | $7,276,000 | +149.4% | 3,602,011 | +234.6% | 0.00% | +300.0% |
| Q4 2021 | $2,917,000 | +12.0% | 1,076,540 | +84.3% | 0.00% | -50.0% |
| Q3 2021 | $2,605,000 | -80.5% | 584,173 | -74.6% | 0.00% | -75.0% |
| Q2 2021 | $13,365,000 | -14.4% | 2,304,374 | +3.6% | 0.01% | -27.3% |
| Q1 2021 | $15,617,000 | +266.0% | 2,224,604 | +150.2% | 0.01% | +266.7% |
| Q4 2020 | $4,267,000 | +502.7% | 889,023 | +631.8% | 0.00% | +200.0% |
| Q3 2020 | $708,000 | -54.4% | 121,492 | -47.2% | 0.00% | -50.0% |
| Q2 2020 | $1,552,000 | -0.1% | 229,919 | -41.8% | 0.00% | 0.0% |
| Q3 2019 | $1,553,000 | -61.4% | 395,237 | +46.0% | 0.00% | -66.7% |
| Q2 2019 | $4,025,000 | +251.5% | 270,710 | +486.9% | 0.01% | +200.0% |
| Q1 2019 | $1,145,000 | +118.9% | 46,124 | +58.5% | 0.00% | +100.0% |
| Q4 2018 | $523,000 | +118.8% | 29,109 | +258.4% | 0.00% | – |
| Q3 2018 | $239,000 | -98.2% | 8,121 | -96.7% | 0.00% | -100.0% |
| Q1 2018 | $13,114,000 | -25.7% | 248,377 | -4.3% | 0.02% | -29.2% |
| Q4 2017 | $17,652,000 | +9.5% | 259,592 | +50.7% | 0.02% | -17.2% |
| Q2 2017 | $16,125,000 | -53.2% | 172,217 | -68.2% | 0.03% | -54.0% |
| Q1 2017 | $34,477,000 | -28.3% | 541,486 | -50.0% | 0.06% | -37.6% |
| Q4 2016 | $48,108,000 | +101.0% | 1,083,034 | +63.1% | 0.10% | +152.5% |
| Q3 2016 | $23,938,000 | +368.9% | 664,024 | +78.5% | 0.04% | +263.6% |
| Q2 2016 | $5,105,000 | -8.4% | 372,099 | +28.1% | 0.01% | -21.4% |
| Q1 2016 | $5,576,000 | -86.4% | 290,411 | -75.3% | 0.01% | -83.7% |
| Q4 2015 | $41,086,000 | +50.0% | 1,173,873 | +294.2% | 0.09% | +62.3% |
| Q3 2015 | $27,386,000 | +671.9% | 297,805 | +523.0% | 0.05% | +657.1% |
| Q1 2015 | $3,548,000 | +30.2% | 47,800 | -1.8% | 0.01% | +16.7% |
| Q4 2014 | $2,725,000 | -75.8% | 48,655 | -80.4% | 0.01% | -79.3% |
| Q3 2014 | $11,278,000 | +330.8% | 248,627 | +293.2% | 0.03% | +314.3% |
| Q2 2014 | $2,618,000 | -84.7% | 63,225 | -74.4% | 0.01% | -86.0% |
| Q1 2014 | $17,110,000 | +41.9% | 247,008 | +23.4% | 0.05% | +31.6% |
| Q4 2013 | $12,062,000 | +79.6% | 200,135 | +81.2% | 0.04% | +72.7% |
| Q3 2013 | $6,716,000 | -74.0% | 110,470 | -71.3% | 0.02% | -72.2% |
| Q2 2013 | $25,813,000 | – | 385,379 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |